Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen
about
Vaccination against hepatitis B: current challenges for Asian countries and future directions.Hepatitis B virus vaccination booster does not provide additional protection in adolescents: a cross-sectional school-based study.Weight-based policy of hepatitis B vaccination in very low birth weight infants in Taiwan: a retrospective cross-sectional study.Hepatitis B serologic survey and review of immunization records of children, adolescents and adults in Fiji, 2008-2009.Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood.CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.A review of strategies to prevent mother-to-infant transmission of hepatitis B virus infection.The immunogenicity of GSK's recombinant hepatitis B vaccine in children: a systematic review of 30 years of experience.Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection.Long-term persistence in protection and response to a hepatitis B vaccine booster among adolescents immunized in infancy in the western region of China.Effect of inclusion of hepatitis B vaccine in childhood immunization program in India: a retrospective cohort study.Chronic hepatitis B infection in adolescents who received primary infantile vaccination.Molecular, immunological and clinical properties of mutated hepatitis B viruses.Persistence of antibody to hepatitis B surface antigen among vaccinated children in a low hepatitis B virus endemic area.Determination of immune memory to hepatitis B vaccination through early booster response in college students.Humoral and cellular immune responses to a hepatitis B vaccine booster 15-18 years after neonatal immunization.Correlation between maternal hepatitis B surface antigen carrier status with social, medical and family factors in an endemic area: have we overlooked something?
P2860
Q33926147-D9C76B0B-C225-48C7-979A-8B0567BB33B0Q34581747-82B8BCB6-9CF6-4041-AA90-D04832AFEA9AQ35123255-9CB5756C-3291-4708-93B3-F6DDB1D10D2EQ35555723-35F489B5-506B-4BC0-ADE4-CB295B6FC9F4Q35887238-CEBD3579-405D-4521-9B79-EAF0BDB95DA5Q36365279-141977AD-8544-4817-99F5-5E81BCF51F89Q38632945-9AB83433-3D21-465B-824D-D66401A5128EQ38674210-A03D1A61-F98D-4AD1-8C9A-99F0823A2143Q39864436-14768BBB-AF35-481E-B744-225901F519A2Q40440788-FADCBDAC-BF42-4F28-AC27-0D01487D3BCDQ41644600-5F02E50D-C354-4707-9C6C-9D840F39EA29Q43502400-4ABA6C73-91D4-4B5F-9E43-BBCBA8947EE5Q43988430-A430E604-9E2C-4754-BADC-EFCDA5DB2A9FQ45363795-45820FAE-3B4E-4637-9232-1FDB5B063DC7Q51886688-D601ADCB-887E-4001-A11B-4B0FCA429EC4Q51965131-C82757CA-45BA-4AC9-90F3-F99B9239CC99Q58029018-BEA944D1-14C3-4B99-885F-1F60332CA549
P2860
Long-term efficacy of recombinant hepatitis B vaccine and risk of natural infection in infants born to mothers with hepatitis B e antigen
description
im Mai 1995 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 May 1995
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 1995
@uk
name
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
type
label
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
prefLabel
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@nl
P1476
Long-term efficacy of recombin ...... ers with hepatitis B e antigen
@en
P304
P356
10.1016/S0022-3476(95)70398-5
P407
P433
P577
1995-05-01T00:00:00Z